
The purpose of this study was to examine the factors which affect the level of fatigue among patients participating in clinical trials in which this symptom had been assessed with the zzso zzso Data were assembled from zzso patients in ten clinical trials in which the zzso had been used to assess baseline and zzso quality of zzso The relationship between the level of fatigue reported by the patients on the fatigue scale of this questionnaire and patient and disease characteristics was assessed in zzso and zzso zzso zzso In addition, changes in fatigue scores were compared in a zzso analysis among patients on two arms of an zzso trial whose zzso control was markedly zzso zzso fatigue levels differed substantially among patients taking part in the different zzso zzso associated with greater fatigue severity on zzso analysis zzso female zzso presence of zzso disease, and poorer performance zzso In addition, on zzso analyses the oldest patients were found to have less fatigue, as were patients with breast cancer, while patients with zzso and lung cancer experienced greater zzso Patients on the arm of the zzso trial in which zzso was better controlled showed significantly less increase in fatigue after receiving zzso The fatigue scale of the zzso appears to provide a useful approach to assessing this important zzso The relationships found between fatigue and patient and disease characteristics need further exploration as does the degree to which the zzso fully captures this dimension of quality of zzso 

